학술논문

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
Document Type
Journal
Source
LANCET NEUROLOGY; MAR 2021, 20 3, p182-p192, 11p.
Subject
Language
English
ISSN
14744465